entrectinib
Ligand Summary
Entrectinib is an inhibitor of the tropomyosin receptor tyrosine kinases (TRK) TRKA, TRKB, and TRKC (encoded by the neurotrophic tyrosine receptor kinase [NTRK] genes NTRK1, NTRK2, and NTRK3, respectively), proto-oncogene tyrosine-protein kinase ROS1 (ROS1), and anaplastic lymphoma kinase (ALK).
UNII: L5ORF0AN1I
PubChem: 25141092
ChEMBL: CHEMBL1983268
DrugCentral: 5345
LyCHI: SQPN7K5NY3NW
Target Activities
31 Activities
Items per page:
10
1 – 10 of 31
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | ||||||
IC50 | ||||||
Ki | ||||||
IC50 | ||||||
Kd | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
Ki | ||||||
Ki | ||||||